In contrast, up-regulated FGF15/19/FGFR4 signaling was found in the FGF21KO mice with increased NASH severity, as evident by hepatocyte injury/repair, fibrosis and potential malignant events. This evidence concerns the gene FGFR4 and metabolic dysfunction-associated steatohepatitis.